The detection technology firm, which focuses on the medical, security, and nuclear markets, said it was proposing a conditional firm placing to raise £20mln through the issue of 80mln shares at a price of 25p each, a 9% discount to its last close price of 27.5p.
The group also proposed an open offer to raise £1mln through the issue of around 4mln shares at the same price.
Kromek said the £21mln it was looking to raise would be used to “significantly increase” its manufacturing capacity and associated working capital to support its medical imaging business, expand sales and marketing for its D3S radiation detection devices, and strengthen its balance sheet to provide flexibility.
The placing was conditional on shareholder approval at a general meeting scheduled to be held at 12 pm on 25 February.
Sir Peter Williams, chairman of Kromek, said over the last three fiscal years the firm had won contracts totalling US$138mln, reflecting “the conversion of our expanding order pipeline and customers increasingly launching next-generation CZT-based products”.
“With the growing demand for our flagship products in all our market segments, this fundraising will strengthen our ability to capitalise on these substantial opportunities. As such, the Board recommends all shareholders to vote in favour of the proposals, which will enable us to deliver increased value to our shareholders."